AOD9604 — The GH Fragment Peptide for Targeted Fat Loss & Body Recomposition
AOD9604 is the fat-targeting fragment of human growth hormone — it replicates HGH's lipolytic effects without the growth-promoting side effects. Here's what the research shows and how it fits looksmaxxing protocols.
The Growth Hormone Fragment That Only Burns Fat
Human growth hormone (GH) has two primary effects relevant to body composition: anabolic effects (muscle growth, tissue repair) and lipolytic effects (fat breakdown). Researchers identified decades ago that these two functions are governed by different portions of the GH molecule.
AOD9604 (Advanced Obesity Drug 9604) is an analogue of the 176-191 fragment of HGH — the specific sequence responsible for lipolytic signaling. By isolating this fragment, researchers can study GH's fat-burning mechanisms without activating the growth-promoting pathways that carry other effects.
Mechanism: How AOD9604 Breaks Down Fat
AOD9604 works through beta-3 adrenergic receptor stimulation and direct effects on fat cell metabolism:
Lipolysis Activation
The peptide activates lipase enzymes within adipocytes (fat cells), triggering the breakdown of stored triglycerides into free fatty acids. These freed fatty acids are then available for oxidation as fuel. This is genuine lipolysis — not appetite suppression or water loss.
Inhibition of Lipogenesis
Simultaneously, AOD9604 appears to inhibit new fat synthesis (lipogenesis). The dual action — breaking down existing fat while preventing new fat storage — creates a favorable adipose tissue environment for body recomposition.
Targeted Adipose Effects
Research suggests AOD9604 has preferential effects on abdominal adipose tissue — the visceral and deep subcutaneous fat that is both metabolically harmful and aesthetically problematic. This makes it particularly relevant for looksmaxxers targeting midsection definition and facial fat reduction.
AOD9604 vs Full HGH for Fat Loss
The advantage of AOD9604 over full GH peptides (like Sermorelin or Ipamorelin) for pure fat loss purposes is specificity:
This makes AOD9604 more appropriate for researchers whose primary goal is fat loss and body recomposition rather than muscle building.
Looksmaxxing Applications
Facial Definition
Buccal fat and sub-chin fat are among the most aesthetically impactful depots. Both appear to respond to AOD9604's lipolytic signal. Researchers report improved jawline definition and reduced facial roundness during AOD9604 protocols — outcomes that dramatically improve facial aesthetics.
Midsection Definition
Abdominal definition is the most sought-after body recomposition outcome. AOD9604's preferential targeting of abdominal adipose makes it directly relevant. Combined with adequate training, the compound can accelerate the rate at which abdominal definition becomes visible.
Skin Quality During Fat Loss
As subcutaneous fat volume decreases, skin quality becomes more visible. Stacking AOD9604 with GHK-Cu or BPC-157 for collagen maintenance helps ensure the skin remains dense and elastic as fat volume reduces — preventing the lax skin appearance that can accompany rapid fat loss.
Research Partner: Compare AOD9604
For side-by-side dosing and mechanism comparisons, LooksMaxingStack's comparison tool covers AOD9604 vs Tirzepatide, Retatrutide, and other metabolic peptides. Their Metabolic Stack guide also covers combined protocols.
Stacking AOD9604
AOD9604 works well alongside:
---
Related Research: Tirzepatide vs Retatrutide 2026 | GH Peptides for Body Recomposition | Looksmaxxing Peptide Stack Protocol 2026
Shop: AOD9604 | 5-Amino-1MQ | CJC-1295 + Ipamorelin | View All Weight Loss Peptides
Research Partner
Compare Peptides Side-by-Side
Use LooksMaxingStack's interactive comparison tool to evaluate peptide mechanisms, half-lives, dosing, and protocols head-to-head.
Explore Research Peptides
Browse our full research peptide catalog — for research use only.
Shop Research PeptidesResearch Use Only: All information is for educational and research purposes. Not medical advice. For research use only. Not for human consumption. Consult a qualified physician.